Academic literature on the topic 'Lutonine A'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Lutonine A.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Lutonine A"

1

Thieme, Marcus, Peter Von Bilderling, Christian Paetzel, Dimitrios Karnabatidis, Julio Perez Delgado, and Michael Lichtenberg. "The 24-Month Results of the Lutonix Global SFA Registry." JACC: Cardiovascular Interventions 10, no. 16 (August 2017): 1682–90. http://dx.doi.org/10.1016/j.jcin.2017.04.041.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Steiner, Sabine, Andrej Schmidt, Yvonne Bausback, Sven Bräunlich, Matthias Ulrich, Ursula Banning-Eichenseer, and Dierk Scheinert. "Single-Center Experience With Lutonix Drug-Coated Balloons in Infrapopliteal Arteries." Journal of Endovascular Therapy 23, no. 3 (April 20, 2016): 417–23. http://dx.doi.org/10.1177/1526602816645080.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Montero-Baker, Miguel. "LEA 13. Lutonix Drug-Coated Balloon Long Lesion Study: 24-Month Outcomes." Journal of Vascular Surgery 68, no. 5 (November 2018): e118. http://dx.doi.org/10.1016/j.jvs.2018.08.024.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Scheinert, Dierk, Stephan Duda, Thomas Zeller, Hans Krankenberg, Jens Ricke, Marc Bosiers, Gunnar Tepe, Scott Naisbitt, and Kenneth Rosenfield. "The LEVANT I (Lutonix Paclitaxel-Coated Balloon for the Prevention of Femoropopliteal Restenosis) Trial for Femoropopliteal Revascularization." JACC: Cardiovascular Interventions 7, no. 1 (January 2014): 10–19. http://dx.doi.org/10.1016/j.jcin.2013.05.022.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Kitrou, P., and P. Kitrou. "03:45 PM Abstract No. 358 The Lutonix Global AV Registry: final 6-month results and subgroup analysis." Journal of Vascular and Interventional Radiology 30, no. 3 (March 2019): S158. http://dx.doi.org/10.1016/j.jvir.2018.12.430.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Metzger, D. Christopher, and Joseph Giorgianni. "TCT-17 The Lutonix Global DCB Registry Real World Patients with Complex Femero-popliteal Lesions – 24 Month Outcomes." Journal of the American College of Cardiology 68, no. 18 (November 2016): B7—B8. http://dx.doi.org/10.1016/j.jacc.2016.09.894.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Trerotola, Scott O., Theodore F. Saad, and Prabir Roy-Chaudhury. "The Lutonix AV Randomized Trial of Paclitaxel-Coated Balloons in Arteriovenous Fistula Stenosis: 2-Year Results and Subgroup Analysis." Journal of Vascular and Interventional Radiology 31, no. 1 (January 2020): 1–14. http://dx.doi.org/10.1016/j.jvir.2019.08.035.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Mustapha, J. A., M. Brodmann, P. J. Geraghty, F. Saab, R. A. Settlage, and M. R. Jaff. "Drug-Coated Versus Uncoated Percutaneous Transluminal Angioplasty in Infra-popliteal Arteries: Six-Month Results of the Lutonix BTK Trial." Journal of Vascular Surgery 70, no. 5 (November 2019): 1718. http://dx.doi.org/10.1016/j.jvs.2019.08.011.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Granada, Juan F., Renu Virmani, Daniel Schulz-Jander, Stefan Tunev, and Robert J. Melder. "Rate of Drug Coating Dissolution Determines In-Tissue Drug Retention and Durability of Biological Efficacy." Journal of Drug Delivery 2019 (January 8, 2019): 1–7. http://dx.doi.org/10.1155/2019/9560592.

Full text
Abstract:
Two different drug-coated balloons (DCBs) possessing different coating formulations were compared for rate of coating dissolution in vitro, in addition to tissue drug concentration and histological responses of treated vascular tissue in vivo, to determine if the rate of drug bioavailability to vascular tissue can impact the degree and duration of the observed pharmacological response to locally delivered drug. In vitro dissolution comparison demonstrated that a urea/paclitaxel-based coating formulation (IN.PACT™ Admiral™) released drug from solid to soluble phase at a slower and constant rate, yielding approximately 7% solubilized drug in 24 h. In contrast, a coating formulated from polysorbate/sorbitol/paclitaxel (Lutonix™) released 51% of solid phase drug to soluble phase in 1 h of dissolution with the remainder solubilizing in 24 h. In vivo evaluation of tissue drug concentration of both products showed significantly different tissue pharmacokinetic profile, with a higher concentration of paclitaxel in tissue at 90 days with a urea-based formulation excipient. Histological comparison of smooth muscle cell loss in response to drug exposure revealed contrasting trends of smooth muscle cell loss from 28 to 90 days with significantly higher response to drug observed at 90 days with the urea-based formulation. Rapid dissolution of drug from the polysorbate/sorbitol coating formulation was associated with an early increase in local cellular response to drug which diminished over 90 days with clearance of local drug from tissue. Sustained long-term drug-in-tissue concentration associated with the urea-based formulation demonstrated sustained pharmacological activity at 90 days, suggesting that slow coating dissolution provides a sustainable long-term tissue response.
APA, Harvard, Vancouver, ISO, and other styles
10

Kolodgie, Frank D., Erica Pacheco, Kazuyuki Yahagi, Hiroyoshi Mori, Elena Ladich, and Renu Virmani. "Comparison of Particulate Embolization after Femoral Artery Treatment with IN.PACT Admiral versus Lutonix 035 Paclitaxel-Coated Balloons in Healthy Swine." Journal of Vascular and Interventional Radiology 27, no. 11 (November 2016): 1676–85. http://dx.doi.org/10.1016/j.jvir.2016.06.036.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Lutonine A"

1

Beaume, Aurore. "Nouveaux accès à des polycycles azotés et carbonés par cascades radicalaires et réactions multi-composants." Paris 6, 2007. http://www.theses.fr/2007PA066285.

Full text
Abstract:
Les cyclisations radicalaires en cascade de précurseurs insaturés conduisent à des polycycles complexes. La cyclisation radicalaire d’ynamides a été utilisée comme étape clé dans la synthèse totale de la mappicine, un alcaloïde polycyclique naturel. Les N-acylcyanamides, analogues azotés des ynamides, ont aussi été engagés dans des cascades radicalaires. La portée et le mécanisme de cette cascade ont été étudiés, notamment grâce à une modélisation faisant appel aux calculs DFT, et une chimiothèque a été synthétisée. La première synthèse totale par voie radicalaire sans étain de la luotonine A a été effectuée. D’autre part, le système palladium/norbornène a été utilisé dans l’élaboration d’une réaction multi-composants donnant accès à des dihydrophénanthrènes dissymétriques.
APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Lutonine A"

1

Commission, Monopolies and Mergers. ARRIVA plc and Lutonian Buses Ltd: A report on the merger situation. London: Stationery Office, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Commission, Monopolies &. Mergers. ARRIVA Plc and Lutonian Buses Ltd. Stationery Office Books, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography